![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2024
Eisenhut, Katharina 
ORCID: https://orcid.org/0000-0001-6448-3126; Faber, Jennifer; Engels, Daniel ORCID: https://orcid.org/0000-0002-9877-6987; Gerhards, Ramona ORCID: https://orcid.org/0000-0002-5398-3632; Lewerenz, Jan ORCID: https://orcid.org/0000-0002-9272-529X; Doppler, Kathrin; Sommer, Claudia ORCID: https://orcid.org/0000-0002-7064-5002; Markewitz, Robert; Falk, Kim K.; Rössling, Rosa ORCID: https://orcid.org/0000-0003-2253-1454; Pruess, Harald; Finke, Carsten ORCID: https://orcid.org/0000-0002-7665-1171; Wickel, Jonathan ORCID: https://orcid.org/0000-0002-5854-3759; Geis, Christian; Ratuszny, Dominica; Pfeffer, Lena K.; Bittner, Stefan; Piepgras, Johannes; Kraft, Andrea; Klausewitz, Jaqueline; Nuscher, Brigitte ORCID: https://orcid.org/0009-0000-4661-0742; Kümpfel, Tania ORCID: https://orcid.org/0000-0001-7509-5268 und Thaler, Franziska S.
(2024):
Early Neuroaxonal Damage in Neurologic Disorders Associated With GAD65 Antibodies.
In: Neurology Neuroimmunology & Neuroinflammation, Bd. 11, Nr. 1
ORCID: https://orcid.org/0000-0001-6448-3126; Faber, Jennifer; Engels, Daniel ORCID: https://orcid.org/0000-0002-9877-6987; Gerhards, Ramona ORCID: https://orcid.org/0000-0002-5398-3632; Lewerenz, Jan ORCID: https://orcid.org/0000-0002-9272-529X; Doppler, Kathrin; Sommer, Claudia ORCID: https://orcid.org/0000-0002-7064-5002; Markewitz, Robert; Falk, Kim K.; Rössling, Rosa ORCID: https://orcid.org/0000-0003-2253-1454; Pruess, Harald; Finke, Carsten ORCID: https://orcid.org/0000-0002-7665-1171; Wickel, Jonathan ORCID: https://orcid.org/0000-0002-5854-3759; Geis, Christian; Ratuszny, Dominica; Pfeffer, Lena K.; Bittner, Stefan; Piepgras, Johannes; Kraft, Andrea; Klausewitz, Jaqueline; Nuscher, Brigitte ORCID: https://orcid.org/0009-0000-4661-0742; Kümpfel, Tania ORCID: https://orcid.org/0000-0001-7509-5268 und Thaler, Franziska S.
(2024):
Early Neuroaxonal Damage in Neurologic Disorders Associated With GAD65 Antibodies.
In: Neurology Neuroimmunology & Neuroinflammation, Bd. 11, Nr. 1
2022
Grueter, Thomas; Moellers, Franziska E.; Tietz, Anja; Dargvainiene, Justina; Melzer, Nico; Heidbreder, Anna; Strippel, Christine; Kraft, Andrea; Hoeftberger, Romana; Schoeberl, Florian; Thaler, Franziska S.; Wickel, Jonathan; Chung, Ha-Yeun; Seifert, Frank; Tschernatsch, Marlene; Nagel, Michael; Lewerenz, Jan; Jarius, Sven; Wildemann, Brigitte C.; de Azevedo, Lucie; Heidenreich, Fedor; Heusgen, Raphaela; Hofstadt-van Oy, Ulrich; Linsa, Andreas; Maass, Jannis Justus; Menge, Til; Ringelstein, Marius; Pedrosa, David J.; Schill, Josef; Seifert-Held, Thomas; Seitz, Caspar; Tonner, Silke; Urbanek, Christian; Zittel, Simone; Markewitz, Robert; Korporal-Kuhnke, Mirjam; Schmitter, Thomas; Finke, Carsten; Brueggemann, Norbert; Bien, Corinna I.; Kleiter, Ingo; Gold, Ralf; Wandinger, Klaus-Peter; Kuhlenbaeumer, Gregor; Leypoldt, Frank und Ayzenberg, Ilya
(2022):
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.
In: Brain, Bd. 146, Nr. 2: S. 600-611
2021
Thaler, Franziska S.; Zimmermann, Luise; Kammermeier, Stefan; Strippel, Christine; Ringelstein, Marius; Kraft, Andrea; Suhs, Kurt-Wolfram; Wickel, Jonathan; Geis, Christian; Markewitz, Robert; Urbanek, Christian; Sommer, Claudia; Doppler, Kathrin; Penner, Loana; Lewerenz, Jan; Rossling, Rosa; Finke, Carsten; Pruss, Harald; Melzer, Nico; Wandinger, Klaus-Peter; Leypoldt, Frank und Kumpfel, Tania
(2021):
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis Real-world Evidence From the GENERATE Registry.
In: Neurology-Neuroimmunology & Neuroinflammation, Bd. 8, Nr. 6, e1088
2019
Bartels, Frederik; Nobis, Katharina; Cooper, Graham; Wendel, Eva; Cleaveland, Robert; Bajer-kornek, Barbara; Blaschek, Astrid; Schimmel, Mareike; Blankenburg, Markus; Baumann, Matthias; Karenfort, Michael; Finke, Carsten und Rostasy, Kevin
(2019):
Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure.
In: Multiple Sclerosis Journal, Bd. 25, Nr. 7: S. 927-936